BIOT
Biotech Acquisition Company Class A Ordinary Shares
BIOT
BIOT
Delisted
BIOT was delisted on the 2nd of February, 2023.
58 hedge funds and large institutions have $146M invested in Biotech Acquisition Company Class A Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
58
Holding in Top 10
–
Calls
$98K
Puts
–
Top Buyers
| 1 | +$5.59M | |
| 2 | +$3.37M | |
| 3 | +$3.07M | |
| 4 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$2.19M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.1M |
Top Sellers
| 1 | -$3.07M | |
| 2 | -$1.2M | |
| 3 | -$1.02M | |
| 4 |
MSU
Mizuho Securities USA
New York
|
-$559K |
| 5 |
EAM
Exos Asset Management
New York
|
-$242K |